Lean Mass Hyper-Responder (LMHR)
In brief
Section titled “In brief”- LMHR: striking lipid profile in lean, fit people on a ketogenic diet
- Characteristics: high LDL, high HDL, low triglycerides
- LDL rise appears physiologically adaptive, not pathological
- Imaging (CAC/CCTA) is leading, not LDL elevation alone
- Treatment focuses on metabolic calm and antioxidative lifestyle
Introduction
Section titled “Introduction”In a portion of people who follow a strict carbohydrate-restricted or ketogenic eating pattern long-term, a striking lipid profile develops with significantly elevated LDL, high HDL and low triglycerides.
This phenotype is referred to as Lean Mass Hyper-Responder (LMHR).
Lipid profile and criteria
Section titled “Lipid profile and criteria”An LMHR profile is usually defined as:
| Parameter | Criterion |
|---|---|
| LDL | ≥5.2 mmol/L |
| HDL | ≥2.1 mmol/L |
| Triglycerides | ≤0.8 mmol/L |
This profile typically develops only after fat adaptation during long-term carbohydrate restriction (less than 25 g carbs/day). Baseline LDL values are often normal.
Mechanism and physiology
Section titled “Mechanism and physiology”The rise in LDL in LMHR appears physiologically adaptive.
| Mechanism | Explanation |
|---|---|
| Fat burning | More LDL circulates to transport fatty acids as energy source to tissues |
| Low body fat percentage | High LDL reflects active fat metabolism, not pathology |
Favorable metabolic markers in LMHR
Section titled “Favorable metabolic markers in LMHR”- Rise in HDL
- Drop in triglycerides
- Low fasting insulin
- Low CRP
Clinical significance and risk assessment
Section titled “Clinical significance and risk assessment”The classic linear relationship between LDL and atherosclerosis doesn’t apply without context.
| Factor | LMHR situation |
|---|---|
| Insulin resistance | Often absent |
| Hypertension | Often absent |
| Systemic inflammation | Often absent |
Vigilance remains warranted for:
Section titled “Vigilance remains warranted for:”- LDL above 7-8 mmol/L
- Progressive calcification or plaque on imaging
- Older age and additional risk factors
Evaluation and monitoring
Section titled “Evaluation and monitoring”Recommended periodic evaluation
Section titled “Recommended periodic evaluation”| Parameter | Frequency |
|---|---|
| Total, LDL, HDL and triglyceride cholesterol | Periodic |
| CRP | Periodic |
| Fasting glucose and insulin | Periodic |
| Blood pressure and body composition | Periodic |
Imaging
Section titled “Imaging”| Indication | Recommendation |
|---|---|
| Significantly elevated LDL or family history | CAC or CCTA indicated |
| Repeat | Every 2-3 years if indication exists |
Treatment strategy
Section titled “Treatment strategy”Lifestyle-focused approach
Section titled “Lifestyle-focused approach”| Advice | Effect |
|---|---|
| Stable blood sugar and low insulin | Maintain |
| Limit oxidizing factors | Smoking, alcohol, linoleic acid-rich oils |
| Use monounsaturated fats | Olive, avocado, macadamia, nut oil |
| Omega-3 from fish or algae | Sufficient intake |
| Vegetables and fiber | Eat plenty |
| Exercise, sleep and recovery | Regular |
Possible diet modification
Section titled “Possible diet modification”| Adjustment | Effect |
|---|---|
| Slight increase in carbohydrates | 50-100 g/day can lower LDL |
| More monounsaturated fats | Shift fat intake |
Medication considerations
Section titled “Medication considerations”| Situation | Recommendation |
|---|---|
| Secondary prevention (after heart attack, stroke, unstable plaque) | Lipid-lowering therapy remains indicated |
| Primary prevention with stable imaging and favorable profile | No convincing benefit of medication; lifestyle and monitoring |
Summary
Section titled “Summary”Veelgestelde vragen
What is a Lean Mass Hyper-Responder (LMHR)?
LMHR is a phenotype in people with low body fat percentage, good fitness and excellent insulin sensitivity who eat ketogenic long-term. They develop a striking lipid profile: LDL ≥5.2 mmol/L, HDL ≥2.1 mmol/L and triglycerides ≤0.8 mmol/L.
Is high LDL in LMHR dangerous?
The classic linear relationship between LDL and atherosclerosis doesn't apply without context. In LMHR, other risk factors are often absent. LDL elevation without inflammation or plaque is not a reliable risk marker in itself. Imaging is leading for risk stratification.
What is the mechanism behind LMHR?
The rise in LDL in LMHR appears to be physiologically adaptive. During fat burning, more LDL circulates to transport fatty acids as an energy source to tissues. High LDL reflects active fat metabolism rather than pathology.
Should LMHR be treated with medication?
In primary prevention with stable imaging and favorable metabolic profile, no convincing benefit of medication has been demonstrated. The goal is not primarily to lower LDL, but to prevent LDL oxidation and endothelial activation through lifestyle.
Medische Disclaimer: De informatie van Stichting Je Leefstijl Als Medicijn over leefstijl, ziektes en stoornissen mag niet worden opgevat als medisch advies. In geen geval adviseren wij mensen om hun bestaande behandeling te veranderen. We raden mensen met chronische aandoeningen aan om zich over hun behandeling goed door bevoegde medische professionals te laten adviseren.
Medical Disclaimer: The information provided by Stichting Je Leefstijl Als Medicijn regarding lifestyle, diseases, and disorders should not be construed as medical advice. Under no circumstances do we advise people to alter their existing treatment. We recommend that people with chronic conditions seek advice regarding their treatment from qualified medical professionals.